Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Conatus Is Gearing Up For A Compelling 2019 With Multiple Catalysts [Seeking Alpha]

CONATUS PHARMACEUTICALS INC (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations
Company Research Source: Seeking Alpha
Conatus Is Gearing Up For A Compelling 2019 With Multiple Catalysts Summary Conatus Pharmaceuticals is expecting to release results from its phase 2b ENCORE-NF study using emricasan to treat patients with NASH fibrosis in the first half of 2019. Results from the phase 2b ENCORE-LF study using emricasan to treat patients with NASH cirrhosis are expected in mid-2019 and it entails a composite primary endpoint of event-free survival. The phase 2b ENCORE-PH study failed to meet the primary endpoint as it relates to HVPG, but an analysis of additional liver function and in clinical outcomes are expected mid-2019. The NASH market is expected to potentially be a $20 billion to $35 billion market opportunity in the coming years. New treatments are needed for patients with NASH cirrhosis because there is on average an estimated 17,000 people on a liver transplant waiting list at any given time. CNAT NASH Fibrosis The first study that is going to be read out is known as the phase 2b ENCORE-NF s Show less Read more
Impact Snapshot
Event Time:
CNAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CNAT alerts
Opt-in for
CNAT alerts

from News Quantified
Opt-in for
CNAT alerts

from News Quantified